CRISPR technology

Top 600 Cancer Drug Targets Ranked Using CRISPR

Researchers from the Wellcome Sanger Institute, GlaxoSmithKline, EMBL-EBI, and Open Targets conducted one of the largest CRISPR screens of cancer genes to date.

Genomics England Reports Positive First Phase of Cancer ctDNA Study

Genomics England said it has generated positive results from the first phase of a collaboration with Inivata and Thermo Fisher Scientific designed to study...
Source: Martin Barraud/Getty Images

10 Countries in 100K Genome Club

These ten governments have committed funding for projects that will sequence a minimum of 100,000 citizens to spur genomic medicine
Precision for Medicine has acquired machine learning-based technology developer SimplicityBio for an undisclosed price

Precision for Medicine Acquires SimplicityBio, Adding AI to QuartzBio Platform

Buyer aims to help pharmaceutical, diagnostic developers maximize the value and utility of biomarker data generated through clinical trials

VA Medical Center Partners with Anixa on Study of AI-Based Liquid Biopsy in Prostate...

Anixa Biosciences said today that for its ongoing study assessing the effectiveness of its Cchek artificial intelligence (AI)-based liquid biopsy in prostate cancer, the...

BGI Americas, AiLife Partner on Clinical WGS Diagnostics for Genetic Disorders

BGI Americas, the U.S. subsidiary of BGI Genomics, will partner with AiLife Diagnostics to jointly develop and market a clinical whole genome sequencing (WGS)...
Extending a collaboration launched last year

Celsee, IncellDx Sign Lung Cancer CTC PD-L1 Agreement

The companies will co-commercialize their respective single-cell technologies for CTCs and PD-L1 expression following positive study results
10x Genomics said today it has acquired Spatial Transcriptomics for an undisclosed price. Based in Stockholm

10x Genomics Maintains Expansion with Spatial Transcriptomics Acquisition

Based in Stockholm, Spatial Transcriptomics offers technology designed to allow RNA sequencing to perform in 2D
Source: Thermo Fisher Scientific

Thermo Fisher Intros New Benchtop NGS Line, Expands Oncomine Assay Offerings

The Ion GeneStudio S5 series' multichip design offers flexibility, while Oncomine portfolio adds liquid biopsy and immuno-oncology assays
Source: Sciepro/Getty Images

Liquid Biopsy for Brain Tumors Now Possible

A method developed at Washington University allows brain tumor mRNA to cross the blood-brain barrier making it available for liquid biopsy
Scroll Up